India, Feb. 17 -- This investment marks a new phase in the industrialisation and expansion of Elitepharm Laboratoires

Freedom International Group (FIG) announces a strategic investment in Elitepharm Laboratoires and becomes one of the major shareholders. FIG is an investment company focusing on technology, finance, health & wellness managing more than 2.5 billion in assets. Elitepharm is a major player in France in the formulation and production of customised dietary supplements.

From research and development to the manufacturing of private-label food supplements, Elitepharm provides solutions for all projects, from small to large series.

Narek Sirakanayan, President & CEO of Freedom International Group, said: "Freedom is making a stra...